Envisioning the Future of Biotech with Alector

Alector is publicly-traded biotech company developing therapies to cure neurodegenerative diseases like Alzheimer's and Frontotemporal Dementia.

Looking to solidify its position as a leader in biomedical research, Alector asked Barrel to design and develop a new website that could match its bold mission. We needed to create an easy-to-navigate experience that could seamlessly showcase Alector's expanse of complicated research and cutting-edge therapeutics.

In order to capture Alector's unique vision, we worked closely with their team to evolve the company’s branding into something sophisticated and intimate. As part of this process, our team created several pieces of original content to elevate the overall brand look. Our use of double exposures (above and below) nods to Alector’s approach of “looking inward to find a cure."

With a growing portfolio of clinical trials and new discoveries on the horizon, Alector also needed a tool to showcase its progress to potential investors. With this in mind, our team developed a series of dynamic diagrams and illustrations, all updatable via Wordpress CMS.

Check out the website at

Related News